FDA Reviewers Raise Concerns About Value Of TransMedic’s OCS Liver System Trial Data
Executive Summary
As experts convene to discuss whether to recommend approval of the device, agency reviewers are concerned about what the primary endpoint and organ selection criteria used in trials mean for safety and efficacy.